ketanserin has been researched along with Hallucination of Body Sensation in 7 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The binding of the selective 5-HT2 antagonist [3H]ketanserin has been investigated in the temporal cortex of patients with Alzheimer's disease (SDAT), Parkinson's disease (PD), senile dementia of Lewy body type (SDLT) and neuropathologically normal subjects (control)." | 3.68 | Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. ( Cheng, AV; Edwardson, JA; Ferrier, IN; Jabeen, S; McKeith, IG; Morris, CM; Perry, EK; Perry, RH; Sahgal, A, 1991) |
| "Well-formed visual hallucinations (VH) are common in patients with Parkinson's disease (PD)." | 1.36 | Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations. ( Brotchie, JM; Darr, T; Fox, SH; Hazrati, LN; Huot, P; Johnston, TH; Pires, D; Visanji, NP, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sommer, IEC | 1 |
| Kleijer, H | 1 |
| Visser, L | 1 |
| van Laar, T | 1 |
| Huot, P | 1 |
| Johnston, TH | 1 |
| Darr, T | 1 |
| Hazrati, LN | 1 |
| Visanji, NP | 1 |
| Pires, D | 1 |
| Brotchie, JM | 1 |
| Fox, SH | 1 |
| Holmes, C | 1 |
| McCulley, M | 1 |
| Nicoll, JA | 1 |
| Alder, JT | 1 |
| Chen, CP | 1 |
| Francis, PT | 1 |
| Liechti, ME | 1 |
| Saur, MR | 1 |
| Gamma, A | 1 |
| Hell, D | 1 |
| Vollenweider, FX | 1 |
| Perry, EK | 2 |
| Marshall, E | 1 |
| Kerwin, J | 1 |
| Smith, CJ | 1 |
| Jabeen, S | 2 |
| Cheng, AV | 2 |
| Perry, RH | 2 |
| Ferrier, IN | 1 |
| Morris, CM | 1 |
| Sahgal, A | 1 |
| McKeith, IG | 1 |
| Edwardson, JA | 1 |
| Sadzot, B | 1 |
| Baraban, JM | 1 |
| Glennon, RA | 1 |
| Lyon, RA | 1 |
| Leonhardt, S | 1 |
| Jan, CR | 1 |
| Titeler, M | 1 |
1 trial available for ketanserin and Hallucination of Body Sensation
| Article | Year |
|---|---|
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
Topics: Adult; Affect; Analysis of Variance; Blood Pressure; Body Temperature; Double-Blind Method; Female; | 2000 |
6 other studies available for ketanserin and Hallucination of Body Sensation
| Article | Year |
|---|---|
Successful treatment of intractable visual hallucinations with 5-HT
Topics: Adult; Female; Hallucinations; Humans; Ketanserin; Serotonin Antagonists; Treatment Outcome | 2018 |
Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Autoradiography; Female; Hallucinations; Humans; Keta | 2010 |
Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Female; Genetic Variation; Genotype; Hallucinations; Humans; In Vitro Techn | 2007 |
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Topics: Acetylcholine; Aged; Aged, 80 and over; Autopsy; Biogenic Amines; Choline O-Acetyltransferase; Demen | 1990 |
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Hallucinations; Humans; Ketanserin; Lewy Bodie | 1991 |
Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.
Topics: Animals; Binding, Competitive; Cerebral Cortex; Hallucinations; Hallucinogens; Humans; In Vitro Tech | 1989 |